Molecular assessment of some cardiovascular genetic risk factors among Iraqi patients with ischemic heart diseases

  • Wisam Jasim Mohammed Molecular Biology Unit Central Public Health Laboratory, Baghdad – Iraq
  • Bassam Musa Sadik Al-Musawi Dept. of Pathology, College of Medicine University of Baghdad Baghdad Iraq
  • Christian Oberkanins ViennaLab Diagnostics GmbH, Gaudenzdorfer Guertel 43‐45, 1120 Vienna, Austria
  • Helene Puhringer ViennaLab Diagnostics GmbH, Gaudenzdorfer Guertel 43‐45, 1120 Vienna, Austria
Keywords: Angiotensin-converting enzyme I/D, ApoE, genetic risk factors, human platelet antigen 1, Iraq, ischemic heart diseases, MTFHR, plasminogen activator inhibitor-1, β-fibrinogen

Abstract

Objective: The underlying molecular basis of ischemic heart diseases (IHDs) has not yet been studied among Iraqi people. This study determined the frequency and types of some cardiovascular genetic risk factors among Iraqi patients with IHDs.

Methods: This is a cross-sectional study recruiting 56 patients with acute IHD during a 2-month period excluding patients >50 years and patients with documented hyperlipidemia. Their ages ranged between 18 and 50 years; males were 54 and females were only 2. Peripheral blood samples were aspirated from all patients for troponin I and DNA testing. Molecular analysis to detect 12 common cardiovascular genetic risk factors using CVD StripAssay® (ViennaLab Diagnostics GmbH, Austria) was performed.

Results: The genotype frequencies of 12 genetic mutations/polymorphisms were as follows: MTHFR A1298C and C677T were the highest reported mutations (62.5% and 50%, respectively), followed by β-fibrinogen gene mutation, homozygous angiotensin-converting enzyme D/D, heterozygous human platelet antigen-1(a/b) polymorphisms, plasminogen activator inhibitor-1 4G/4G, homozygous E4 allele of apolipoprotein E gene, Leu allele of Factor XIII V34L variant, heterozygous FV R2, Factor V Leiden mutation, prothrombin G20210A mutation, respectively. Genetic risk scores were calculated and a number ranging from 0 to 8 were given to each patient. None (0%) had a risk score >6 or <2; 22 (39.3%) patients had a risk score of 4 and >60% of cases had a risk score of 4 or more.

Conclusion: The obtained results constitute a reference guide where future studies on normal people and older IHD patients can rely on to determine whether these can be used for pre-clinical risk assessment.

Published
2018-04-19
How to Cite
Mohammed, W., Al-Musawi, B., Oberkanins, C., & Puhringer, H. (2018). Molecular assessment of some cardiovascular genetic risk factors among Iraqi patients with ischemic heart diseases. International Journal of Health Sciences, 12(3). Retrieved from https://ijhs.org.sa/index.php/journal/article/view/2244
Section
Original Paper